Biogen Inc (BIIB)

275.23
NASDAQ : Health Care
Prev Close 275.23
Day Low/High 0.00 / 0.00
52 Wk Low/High 223.02 / 333.65
Avg Volume 1.73M
Exchange NASDAQ
Shares Outstanding 215.95M
Market Cap 59.35B
EPS 17.00
P/E Ratio 16.23
Div & Yield N.A. (N.A)

Latest News

European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details

European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details

European stocks drifted lower Monday following a holiday-thinned trading session in Asia as investors prepare for key inflation and private sector activity data later in the week.

European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade

European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade

European stocks are expected to open mixed Monday following a holiday-thinned trading session in Asia as investors prepare for key inflation and private sector activity data later in the week.

Week in Review: Stocks Post Small Gains After Fed Pulls Trigger on Third Hike Since Crisis

Week in Review: Stocks Post Small Gains After Fed Pulls Trigger on Third Hike Since Crisis

Wall Street ends with modest gains in a week in which the Federal Reserve decided to pull the trigger on an interest rate hike.

Dow, S&P 500 Decline as Health Care Losses Counter Gains

Dow, S&P 500 Decline as Health Care Losses Counter Gains

Wall Street ends a jampacked week little changed as a selloff in health care stocks counters broad gains elsewhere.

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Stocks rise on Friday even as a selloff in health care extends into its second day.

Midday Report: Amgen Leads Health Care Lower; U.S. Stocks Fall

Midday Report: Amgen Leads Health Care Lower; U.S. Stocks Fall

Stocks creep lower on Friday as a selloff in health care extends into its second day, this time led by Amgen shares.

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks creep lower on Friday as a selloff in health care extends into its second day.

Dow, S&P 500 Retreat From Rally as Health Care Selloff Interrupts Fed Boost

Dow, S&P 500 Retreat From Rally as Health Care Selloff Interrupts Fed Boost

Investor sentiment soured on Thursday as a selloff in health care challenges optimism over the Federal Reserve's decision to raise interest rates.

S&P 500 Trades Lower as Health Care Sells Off, Crude Fluctuates

S&P 500 Trades Lower as Health Care Sells Off, Crude Fluctuates

Stocks are slightly lower by early afternoon Thursday as a selloff in health care challenges optimism over the Federal Reserve's decision to raise interest rates.

Cramer: Confusion Reigns in This Market

Cramer: Confusion Reigns in This Market

Many want to undo what's been done, but not enough to send the market down.

Midday Report: Biogen Weighs on Health Care Stocks; U.S. Markets Fall

Midday Report: Biogen Weighs on Health Care Stocks; U.S. Markets Fall

Stocks give back earlier gains as a selloff in health care overshadows the Federal Reserve's decision a day earlier to raise interest rates.

Stocks Extend Declines as Biogen Leads Health Care Selloff

Stocks Extend Declines as Biogen Leads Health Care Selloff

Early morning gains quickly evaporate on Thursday as a selloff in health care overshadows the Federal Reserve's decision a day earlier to raise interest rates.

Analysts' Actions -- Liberty Global, RPM International, TJX, Biogen and More

Analysts' Actions -- Liberty Global, RPM International, TJX, Biogen and More

Here are Thursday's top research calls, including upgrades of TJX Companies, Liberty Global and RPM International, and downgrades of Biogen, Sunworks and Tredegar.

Biogen Appoints Anirvan Ghosh Senior Vice President, Research And Early Development

Biogen Appoints Anirvan Ghosh Senior Vice President, Research And Early Development

Biogen (NASDAQ:BIIB) today announced the appointment of Anirvan Ghosh, Ph.

Neurotrope Shares Soar as Alzheimer's Drug Trial Lottery Ticket Call Nears

Neurotrope Shares Soar as Alzheimer's Drug Trial Lottery Ticket Call Nears

Despite all the prior failures and blowups, an Alzheimer's drug study -- no matter how unlikely to succeed -- remains an irresistible lure for some investors.

Celgene's Deep Pipeline Can Reassure Investors

Celgene's Deep Pipeline Can Reassure Investors

This biotech company is trading at a bargain compared to its peer group.

Biogen To Present At The Cowen & Company 37th Annual Health Care Conference

Biogen To Present At The Cowen & Company 37th Annual Health Care Conference

Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Cowen & Company 37 th Annual Health Care Conference.

After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B

After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B

Perrigo also said it will review its API business, which provides differentiated active pharmaceutical ingredients and finished dosage forms for the branded and generic industries.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Ring the Register With These Upcoming Spinoffs

Ring the Register With These Upcoming Spinoffs

Numerous studies show that corporate carve outs deliver robust returns.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABMD, ABX, AEM, BGG, BIIB, HBM, HTBI, KALU, MNTA, NEWM, NQ, SNE, VMI, VPG, WMT, XCRA Downgrades: CGNX, DAKT, EXAC, FSLR, HOLI, PFLT Initiations: AGR Read on to get TheStreet Quant Ratings' detailed report:

Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial

Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial

Ozanimod is part of Celgene's strategy to grow its inflammation and immunology business as a diversification hedge away from Revlimid, the blockbuster blood cancer drug.

Biogen To Present At The 2017 RBC Capital Markets Global Healthcare Conference

Biogen To Present At The 2017 RBC Capital Markets Global Healthcare Conference

Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the 2017 RBC Capital Markets Global Healthcare Conference.

Cramer: Allergan Is the New Pharma Growth Stock

Cramer: Allergan Is the New Pharma Growth Stock

Jim Cramer compares Allergan's growth to other pharma stocks.

Biogen To Present At The Leerink Partners 6th Annual Global Healthcare Conference

Biogen To Present At The Leerink Partners 6th Annual Global Healthcare Conference

Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Leerink Partners 6 th Annual Global Healthcare Conference.

Analysts' Actions -- Apple, Biogen, Caterpillar, Micron and More

Analysts' Actions -- Apple, Biogen, Caterpillar, Micron and More

Here are Tuesday's top research calls, including upgrades for Biogen and Caterpillar, and increased price targets for Apple and Micron.

Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet

Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet

The company's shares jumped 5% midday Friday on rumors that Astrazeneca could buy Acadia.